EF
AVIR icon

Empowered Funds’s Atea Pharmaceuticals AVIR Stock Holding History

Empowered Funds’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$266K Buy
+49,469
New +$227K ﹤0.01% 1878

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Empowered Funds's AVIR Position: Q1 2026 in Review

Empowered Funds opened a new position in Atea Pharmaceuticals (AVIR) in Q1 2026: 49,469 shares worth $266K. The stake represents ﹤0.01% of the portfolio and ranks #1878 among its holdings.

127 funds tracked by Wall St. Rank hold AVIR as of Q1 2026.

  • Empowered Funds held 49,469 shares of Atea Pharmaceuticals worth $266K as of Q1 2026.
  • Atea Pharmaceuticals was a new Empowered Funds position in Q1 2026.
  • Atea Pharmaceuticals made up ﹤0.01% of Empowered Funds's portfolio in Q1 2026, its #1878 holding.
  • 127 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.